YGW-17497-06202
4 vaccinations
1 coded response
22 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 551 / MN
- Registered
- 2021-04-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-23
Dose 1 — Pfizer-BioNTech
-
2021-04-14
Dose 2 — Pfizer-BioNTech
-
2021-04-18
Registered in v-safe
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-28
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-07-16
- 2021-10-13
-
2021-11-01
Dose 3 — Pfizer-BioNTech
- 2022-04-14
-
2022-10-12
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-18
- 2022-10-19
- 2022-10-26
- 2022-11-04
- 2022-11-09
-
2022-11-16
Survey response — day 35, dose 4MedDRA: Dizziness, Nasopharyngitis — Feeling: FairFree text: Head cold, light headedMedDRA releases: 2024-11 · check-in free text available
- 2022-11-23
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-23 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2021-11-01 | Pfizer-BioNTech | No |
| 4 | 2022-10-12 | Pfizer-BioNTech | Flu |
Free text
Release 12 — day 35, dose 4
Symptoms: Head cold, light headed
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release